Cargando…

Tumefactive demyelination with a transient appearance of oligoclonal bands in MS under fingolimod

Detalles Bibliográficos
Autores principales:	Okada, Kazumasa, Hashimoto, Tomoyo, Kobata, Masako, Kakeda, Shingo, Takahashi, Toshiyuki, Hirato, Junko
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2018
Materias:	Clinical/Scientific Notes
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6039211/ https://www.ncbi.nlm.nih.gov/pubmed/29998159 http://dx.doi.org/10.1212/NXI.0000000000000484

Ejemplares similares

Case Report: Paraneoplastic Tumefactive Demyelination Associated With Seminoma
por: Shiraishi, Wataru, et al.
Publicado: (2022)

Recurrent tumefactive demyelination: An unusual presentation
por: Bhargava, Amita, et al.
Publicado: (2015)

A Case of Relapsing-Remitting Tumefactive Demyelination
por: Wadhwa, Ankur, et al.
Publicado: (2019)

Isolated Medullary Tumefactive Demyelination Masquerading as Tumor
por: Manoj,, et al.
Publicado: (2022)

Recurrent tumefactive demyelinating lesions in an elderly woman
por: Weil, Erika L., et al.
Publicado: (2022)

Tumefactive demyelinating disease with isolated spinal cord involvement
por: Makary, Mina S, et al.
Publicado: (2014)

Silent Tumefactive Demyelinating Lesions and Radiologically Isolated Syndrome
por: Ekmekci, Ozgul, et al.
Publicado: (2018)

Tumefactive demyelination: Clinical outcomes, lesion evolution and treatments
por: Brod, Staley A, et al.
Publicado: (2019)

Tumefactive demyelination following herbal supplement use: Cause or coincidence?
por: Dubey, D, et al.
Publicado: (2016)

Progression of tumefactive demyelinating lesion in a child demonstrated with MRI
por: De Simone, Marta, et al.
Publicado: (2017)

Tumefactive demyelination in a patient with relapsing-remitting MS on ocrelizumab
por: Moreira Ferreira, Vanessa F., et al.
Publicado: (2019)

AZD-1222: Tumefactive demyelinating brain lesion : case report
Publicado: (2022)

Tumefactive Demyelination—A Rare Presentation of Anti-MOG Syndrome
por: Sivadasan, Sesh, et al.
Publicado: (2022)

Prospective Identification of Oligoclonal/Abnormal Band of the Same Immunoglobulin Type as the Malignant Clone by Differential Location of M-Spike and Oligoclonal Band
por: Vyas, Shikhar G., et al.
Publicado: (2017)

Comparing clinical and imaging features of patients with MOG antibody-positivity and with and without oligoclonal bands
por: Tomizawa, Yuji, et al.
Publicado: (2023)

Pitfalls in the diagnosis of a tumefactive demyelinating lesion: A case report
por: Gavra, Maria, et al.
Publicado: (2011)

Neuroimaging features of tumefactive demyelinating lesions: A rare case report
por: Febyan, et al.
Publicado: (2020)

Immunopathology of Tumefactive Demyelinating Lesions-From Idiopathic to Drug-Related Cases
por: Vakrakou, Aigli G., et al.
Publicado: (2022)

Clinical spectrum and prognosis of pathologically confirmed atypical tumefactive demyelinating lesions
por: Zhang, Yajing, et al.
Publicado: (2023)

‘Beta-interferons’ and ‘oligoclonal bands’ in multiple sclerosis in India
por: Hassan, K. M.
Publicado: (2011)

Case Report: Persisting Lymphopenia During Neuropsychiatric Tumefactive Multiple Sclerosis Rebound Upon Fingolimod Withdrawal
por: Koska, Valeria, et al.
Publicado: (2021)

Chinese Guidelines for the Diagnosis and Management of Tumefactive Demyelinating Lesions of Central Nervous System
Publicado: (2017)

Tumefactive Demyelination Associated with Bilateral Optic Neuritis in Neuromyelitis Optica Spectrum Disorders
por: Verma, Rajesh, et al.
Publicado: (2019)

Tumefactive demyelination after covid-19 successfully treated with betainterferon 1A
por: Araújo, Victor Oliveira, et al.
Publicado: (2022)

Defining the natural history of tumefactive demyelination: A retrospective cohort of 257 patients
por: Fereidan‐Esfahani, Mahboubeh, et al.
Publicado: (2023)

Immunodetection of oligoclonal bands in serum and CSF of Multiple Sclerosis patients
Publicado: (2015)

Oligoclonal Bands in Cerebrospinal Fluid of Black Patients with Multiple Sclerosis
por: da Gama, Paulo Diniz, et al.
Publicado: (2015)

Cerebrospinal fluid oligoclonal bands in Neuroborreliosis are specific for Borrelia burgdorferi
por: Berek, Klaus, et al.
Publicado: (2020)

A rare presentation of atypical demyelination: tumefactive multiple sclerosis causing Gerstmann’s syndrome
por: Gnanapavan, Sharmilee, et al.
Publicado: (2014)

Corrigendum: Chinese Guidelines for the Diagnosis and Management of Tumefactive Demyelinating Lesions of Central Nervous System
Publicado: (2017)

Paraneoplastic recurrent tumefactive demyelination in a 62-year-old man with metastatic seminoma
por: Thebault, Simon, et al.
Publicado: (2018)

When tumefactive demyelination is truly a tumor: case report of a radiographic misdiagnosis
por: Taylor, Breanna, et al.
Publicado: (2021)

In multiple sclerosis, oligoclonal bands connect to peripheral B-cell responses
por: Bankoti, Jaishree, et al.
Publicado: (2014)

Association of Genetic Markers with CSF Oligoclonal Bands in Multiple Sclerosis Patients
por: Leone, Maurizio A., et al.
Publicado: (2013)

Detection of Oligoclonal Ig Bands: Clinical Significance and Trends in Methodological Improvement
por: Trbojevic–Cepe, Milica
Publicado: (2004)

Evidence of Oligoclonal Bands Does Not Exclude Non-Inflammatory Neurological Diseases
por: Pannewitz-Makaj, Katharina, et al.
Publicado: (2020)

CSF oligoclonal IgG bands are not associated with ALS progression and prognosis
por: Klose, Veronika, et al.
Publicado: (2023)

Absence of Oligoclonal Bands in Multiple Sclerosis: A Call for Differential Diagnosis
por: Katsarogiannis, Evangelos, et al.
Publicado: (2023)

Neuromyelitis Optica Spectrum Disorder with Tumefactive Demyelination mimicking Multiple Sclerosis: A Rare Case
por: Roy, Ujjawal, et al.
Publicado: (2016)

Successful treatment of HIV-associated tumefactive demyelinating lesions with corticosteroids and cyclophosphamide: a case report
por: Lazzarin, Serena Marita, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_o3gha0ij50bnrp8nerqnppmpro